Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Clinical Pharmacology and Therapeutics
|
January 1, 1985
Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension
M H Maxwell, J Brachfeld, H Itskovitz, et al.
The Journal of Clinical Psychiatry
|
August 1, 1978
Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia
L F Fabre, J Brachfeld, L R Meyer, et al.
JAMA
|
October 24, 1986
A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response
L X Cubeddu, J Aranda, B Singh, et al.
Archives of Internal Medicine
|
August 1, 1988
Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity
T D Giles, G E Sander, L Roffidal, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Clinical Pharmacology and Therapeutics
|
January 1, 1985
Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension
M H Maxwell, J Brachfeld, H Itskovitz, et al.
The Journal of Clinical Psychiatry
|
August 1, 1978
Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia
L F Fabre, J Brachfeld, L R Meyer, et al.
JAMA
|
October 24, 1986
A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response
L X Cubeddu, J Aranda, B Singh, et al.
Archives of Internal Medicine
|
August 1, 1988
Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity
T D Giles, G E Sander, L Roffidal, et al.
Page
of 2